All Posts

The biotech and biopharma sectors are navigating an increasingly volatile terrain marked by accelerated scientific breakthroughs, evolving global regulatory dynamics, and intensifying cost-containment pressures. AI-driven changes in regulatory, shifting vaccine advisory paradigms, assertive pricing frameworks, and renewed scrutiny around IP protections are redefining the competitive environment.

Competitive Intelligence (CI) and Market Intelligence (MI) professionals operate in a world where political shifts, both sweeping and subtle, are constant. These shifts — from evolving regulatory landscapes and economic policies to geopolitical stability and information accessibility — profoundly influence how businesses gather, analyze, and leverage competitive and market insights. Understanding this intricate relationship, both explicit and implicit, is crucial for effectiv

We recently hosted a webinar titled Intelligent Bidding – Using Competitive and Customer Insights to Win More, and we were thrilled to welcome over 200 participants from across industries. The level of engagement during the Q&A was outstanding, a clear sign that this topic resonates with those responsible for crafting high-impact proposals.